Business Today US India IPR FDA Pharma Sector
Business Today
Alchemy by E Kumar Sharma

The key point is not what the family-led businesses in India are doing, but the growing awareness on the need for succession planning.

We perhaps need to ask, why is it that for a disease like swine flu, we have people dying in the country today?
Is India yielding ground to the US on intellectual property rights? Apprehensions abound both in India and abroad.
In particular, developments expected in February and September could pave the way forward for financial inclusion in the country.